Abstract

Latent membrane protein 1 (LMP1), an Epstein-Barr virus transforming protein, is able to activate NF-kappaB through its carboxyl-terminal activation region 1 (CTAR1) and 2 (CTAR2), but the exact role of each domain is not fully understood. Here we show that LMP1 activates NF-kappaB in different NF-kappaB essential modulator (NEMO)-defective cell lines, but not in cells lacking both IkappaB kinase 1 (IKK1) and 2 (IKK2). Mutational studies reveal that CTAR1, but not CTAR2, mediates NEMO-independent NF-kappaB activation and that this process largely depends on IKK1. Retroviral expression of LMP1 mutants in cells lacking either functional NF-kappaB inducing kinase (NIK), NEMO, IKK1, or IKK2 further illustrates distinct signals from the two activation regions of LMP1 for persistent NF-kappaB activation. One originates in CTAR2, operates through the canonical NEMO-dependent pathway, and induces NFKB2 p100 production; the second signal originates in CTAR1, utilizes NIK and IKK1, and induces the processing of p100. Our results thus help clarify how two functional domains of LMP1 persistently activate NF-kappaB through distinct signaling pathways.

Highlights

  • Latent membrane protein-1 (LMP1)1 is an oncogenic transmembrane protein encoded by Epstein-Barr virus [1,2,3] that is known to activate NF-␬B [4, 5], the c-Jun NH2-terminal kinase pathway [6], and its downstream transcription factors such as AP-1 (6 – 8), Janus-activating tyrosine kinase 3 and signal transducer and activator of transcription [9], and p38 mitogenactivated protein kinase [10]

  • The entire coding region of the nemo cDNA expressed in Rat-1 cells was cloned by reverse transcription-polymerase chain reaction (RT-PCR), using primers corresponding to regions highly conserved between the human and murine nemo genes (Fig. 1A)

  • Semiquantitative PCR analysis revealed more than 1000 copies of nemo cDNA in the sample prepared from 100 Rat-1 cells, whereas none was detected in 100 5R cells (Fig. 1C)

Read more

Summary

Introduction

Latent membrane protein-1 (LMP1)1 is an oncogenic transmembrane protein encoded by Epstein-Barr virus [1,2,3] that is known to activate NF-␬B [4, 5], the c-Jun NH2-terminal kinase pathway [6], and its downstream transcription factors such as AP-1 (6 – 8), Janus-activating tyrosine kinase 3 and signal transducer and activator of transcription [9], and p38 mitogenactivated protein kinase [10]. Retroviral expression of LMP1 in Rat-1 and 5R cells caused similar enhancement of IKK1-associated kinase activity determined in vitro on recombinant I␬B␣ protein, when the IKK complex was immunoprecipitated with an IKK1-specific antibody at 30 h after infection (Fig. 3A, left upper panel).

Results
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.